Results of New Intervention Trials in People at Clinical High Risk of Psychosis

被引：0
|
作者：
不详
机构：
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [21] Coping as a predictor of treatment outcome in people at clinical high risk of psychosis
    Kommescher, Mareike
    Wagner, Michael
    Puetzfeld, Verena
    Berning, Julia
    Janssen, Birgit
    Decker, Petra
    Bottlender, Ronald
    Moeller, Hans-Juergen
    Gaebel, Wolfgang
    Maier, Wolfgang
    Klosterkoetter, Joachim
    Bechdolf, Andreas
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 (01) : 17 - 27
  • [22] Sources of clinical distress in young people at ultra high risk of psychosis
    Rapado-Castro, Marta
    McGorry, Patrick D.
    Yung, Alison
    Calvo, Ana
    Nelson, Barnaby
    [J]. SCHIZOPHRENIA RESEARCH, 2015, 165 (01) : 15 - 21
  • [23] Theory of mind and social judgments in people at clinical high risk of psychosis
    Healey, Kristin M.
    Penn, David L.
    Perkins, Diana
    Woods, Scott W.
    Addington, Jean
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 498 - 504
  • [24] Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
    Allen, Paul
    Moore, Holly
    Corcoran, Cheryl M.
    Gilleen, James
    Kozhuharova, Petya
    Reichenberg, Avi
    Malaspina, Dolores
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 10
  • [25] Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
    Davies, Cathy
    Paloyelis, Yannis
    Rutigliano, Grazia
    Cappucciati, Marco
    De Micheli, Andrea
    Ramella-Cravaro, Valentina
    Provenzani, Umberto
    Antoniades, Mathilde
    Modinos, Gemma
    Oliver, Dominic
    Stahl, Daniel
    Murguia, Silvia
    Zelaya, Fernando
    Allen, Paul
    Shergill, Sukhi
    Morrison, Paul
    Williams, Steve
    Taylor, David
    McGuire, Philip
    Fusar-Poli, Paolo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (07) : 1300 - 1309
  • [26] Influence of cannabis use on incidence of psychosis in people at clinical high risk
    Chester, Lucy A.
    Valmaggia, Lucia R.
    Kempton, Matthew J.
    Chesney, Edward
    Oliver, Dominic
    Hedges, Emily P.
    Klatsa, Elise
    Stahl, Daniel
    van der Gaag, Mark
    de Haan, Lieuwe
    Nelson, Barnaby
    McGorry, Patrick
    Amminger, G. Paul
    Riecher-Rossler, Anita
    Studerus, Erich
    Bressan, Rodrigo
    Barrantes-Vidal, Neus
    Krebs, Marie-Odile
    Glenthoj, Birte
    Nordentoft, Merete
    Ruhrmann, Stephan
    Sachs, Gabriele
    McGuire, Philip
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (09) : 469 - 477
  • [27] Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
    Cathy Davies
    Yannis Paloyelis
    Grazia Rutigliano
    Marco Cappucciati
    Andrea De Micheli
    Valentina Ramella-Cravaro
    Umberto Provenzani
    Mathilde Antoniades
    Gemma Modinos
    Dominic Oliver
    Daniel Stahl
    Silvia Murguia
    Fernando Zelaya
    Paul Allen
    Sukhi Shergill
    Paul Morrison
    Steve Williams
    David Taylor
    Philip McGuire
    Paolo Fusar-Poli
    [J]. Neuropsychopharmacology, 2019, 44 : 1300 - 1309
  • [28] Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis
    Zimbron, J.
    Ruiz de Azua, S.
    Khandaker, G. M.
    Gandamaneni, P. K.
    Crane, C. M.
    Gonzalez-Pinto, A.
    Stochl, J.
    Jones, P. B.
    Perez, J.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2013, 127 (03) : 210 - 216
  • [29] STRESS IN PEOPLE AT HIGH RISK FOR PSYCHOSIS
    Day, F.
    Valmaggia, L.
    Pariante, C.
    Papadopoulos, A.
    Papadopoulos, I.
    McGuire, P.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [30] Clinical Presentation of and Social Risk Factors in Young People at Cinical High Risk for Psychosis
    Addington, Jean
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 106S - 106S
12345